Environmental Health Perspectives · 1998 · 164 citations · 48 references
PharmacyEnvironmental SciencesToxicologyEcotoxicologyEnvironmental HealthEnvironmental ToxicologyCarcinogenicity AssessmentEnvironmental CarcinogenesisEnvironmental CarcinogensMixture ToxicityToxicity Risk AssessmentCancer Risk AssessmentCarcinogenicity Risk AssessmentChemical TransformationDioxinsEarly Life Environmental ExposuresEnvironmental MixturesMixture Risk AssessmentPolychlorinated Biphenyl Toxicity
A new approach to assessing the cancer risk from environmental polychlorinated biphenyls (PCBs) considers both toxicity and environmental processes to make distinctions among environmental mixtures. New toxicity information from a 1996 cancer study of four commercial mixtures strengthens the case that all PCB mixtures can cause cancer, although different mixtures have different potencies. Environmental processes alter PCB mixtures through partitioning, chemical transformation, and preferential bioaccumulation; these processes can increase or decrease toxicity considerably. Bioaccumulated PCBs are of greatest concern because they appear to be more toxic than commercial PCBs and more persistent in the body. The new approach uses toxicity studies of commercial mixtures to develop a range of cancer potency estimates and then considers the effect of environmental processes to choose appropriate values for representative classes of environmental mixtures. Guidance is given for assessing risks from different exposure pathways, less-than-lifetime and early-life exposures, and mixtures containing dioxinlike compounds.
48
Toxic equivalency factors for dioxin-like PCBs
UG Ahlborg, G.C. Becking, LS Birnbaum et al. · Chemosphere · 1994 · 717 citations
D.E. Schulz, Gert Petrick, J.C. Duinker · Environmental Science & Technology · 1989 · 635 citations
George M. Frame, Jack Cochran, Søren Bøwadt · Journal of High Resolution Chromatography · 1996 · 549 citations
Pharmacy, Chemistry, Toxicology +16
Fundamental carcinogenic processes and their implications for low dose risk assessment.
Kenny S. Crump, David G. Hoel, Charles H. Langley et al. · PubMed · 1976 · 277 citations
Medicine, Toxicology, Carcinogenesis +14